Corrigendum to “Cellular landscaping of cisplatin resistance in cervical cancer” Biomed. Pharmacother. 153(2022) 113345 (Biomedicine & Pharmacotherapy (2022) 153, (S075333222200734X), (10.1016/j.biopha.2022.113345))

dc.contributorAalto-yliopistofi
dc.contributorAalto Universityen
dc.contributor.authorBhattacharjee, Rahulen_US
dc.contributor.authorDey, Tanimaen_US
dc.contributor.authorKumar, Lamhaen_US
dc.contributor.authorKar, Sulagnaen_US
dc.contributor.authorSarkar, Ritayanen_US
dc.contributor.authorGhorai, Mimosaen_US
dc.contributor.authorMalik, Sumiraen_US
dc.contributor.authorJha, Niraj Kumaren_US
dc.contributor.authorVellingiri, Balachandaren_US
dc.contributor.authorKesari, Kavindra Kumaren_US
dc.contributor.authorPérez de la Lastra, José M.en_US
dc.contributor.authorDey, Abhijiten_US
dc.contributor.departmentDepartment of Applied Physicsen
dc.contributor.departmentDepartment of Bioproducts and Biosystemsen
dc.contributor.organizationKalinga Institute of Industrial Technologyen_US
dc.contributor.organizationIndian Institute of Science Education and Research Thiruvananthapuramen_US
dc.contributor.organizationPresidency College Indiaen_US
dc.contributor.organizationAmity University Jharkhanden_US
dc.contributor.organizationSharda Universityen_US
dc.contributor.organizationBharathiar Universityen_US
dc.contributor.organizationInstituto de Productos Naturales y Agrobiologiaen_US
dc.date.accessioned2024-08-06T07:35:25Z
dc.date.available2024-08-06T07:35:25Z
dc.date.issued2024-08en_US
dc.descriptionPublisher Copyright: © 2024 The Authors
dc.description.abstractThe authors regret that incorrect information was given in the citation list of the publication The incorrect references and their corrections are as follows: Reference 27 should be same as reference 245 Reference 75 should be same as reference 82 Reference 274 should be same as reference 276 Reference 53 should be: Li, Q., Peng, X., Yang, H., Rodriguez, J. A., & Shu, Y. (2012). Contribution of organic cation transporter 3 to cisplatin cytotoxicity in human cervical cancer cells. Journal of pharmaceutical sciences, 101(1), 394–404. Reference 61 Should be: Waalkes, M. P., Liu, J., Kasprzak, K. S., & Diwan, B. A. (2006). Hypersusceptibility to cisplatin carcinogenicity in metallothionein-I/II double knockout mice: Production of hepatocellular carcinoma at clinically relevant doses. International journal of cancer, 119(1), 28–32. https://doi.org/10.1002/ijc.21245 References 69, and 73 should be: Wang, N., Hou, M. S., Zhan, Y., Shen, X. B., & Xue, H. Y. (2018). MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway. European Review for Medical & Pharmacological Sciences, 22(22). Reference 96 should be: Chen SH, Chang JY. New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment. Int J Mol Sci. 2019 Aug 24;20(17):4136. doi: 10.3390/ijms20174136 Reference 229 should be: O′Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018). Overview of microRNA biogenesis, mechanisms of actions, and circulation. Frontiers in endocrinology, 9, 402. Reference 247 should be: Schräder, M., Nayeri, S., Kahlen, J. P., Müller, K. M., & Carlberg, C. (1995). Natural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation. Molecular and cellular biology, 15(3), 1154–1161. References 4, 156, 180, 199, 270, 273, are unnecessary and can be deleted The authors would like to apologise for any inconvenience caused.en
dc.description.versionPeer revieweden
dc.format.extent1
dc.format.mimetypeapplication/pdfen_US
dc.identifier.citationBhattacharjee, R, Dey, T, Kumar, L, Kar, S, Sarkar, R, Ghorai, M, Malik, S, Jha, N K, Vellingiri, B, Kesari, K K, Pérez de la Lastra, J M & Dey, A 2024, 'Corrigendum to “Cellular landscaping of cisplatin resistance in cervical cancer” Biomed. Pharmacother. 153(2022) 113345 (Biomedicine & Pharmacotherapy (2022) 153, (S075333222200734X), (10.1016/j.biopha.2022.113345))', Biomedicine & Pharmacotherapy, vol. 177, 117097. https://doi.org/10.1016/j.biopha.2024.117097en
dc.identifier.doi10.1016/j.biopha.2024.117097en_US
dc.identifier.issn0753-3322
dc.identifier.issn1950-6007
dc.identifier.otherPURE UUID: 37882581-8450-428d-a9b5-7fe1679d7a54en_US
dc.identifier.otherPURE ITEMURL: https://research.aalto.fi/en/publications/37882581-8450-428d-a9b5-7fe1679d7a54en_US
dc.identifier.otherPURE FILEURL: https://research.aalto.fi/files/150970239/Corrigendum_to_Cellular_landscaping_of_cisplatin_resistance_in_cervical_cancer_Biomed._Pharmacother.pdf
dc.identifier.urihttps://aaltodoc.aalto.fi/handle/123456789/129634
dc.identifier.urnURN:NBN:fi:aalto-202408065207
dc.language.isoenen
dc.publisherElsevier
dc.relation.ispartofseriesBiomedicine & Pharmacotherapyen
dc.relation.ispartofseriesVolume 177en
dc.rightsopenAccessen
dc.titleCorrigendum to “Cellular landscaping of cisplatin resistance in cervical cancer” Biomed. Pharmacother. 153(2022) 113345 (Biomedicine & Pharmacotherapy (2022) 153, (S075333222200734X), (10.1016/j.biopha.2022.113345))en
dc.typeComment/debatefi
dc.type.versionpublishedVersion

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Corrigendum_to_Cellular_landscaping_of_cisplatin_resistance_in_cervical_cancer_Biomed._Pharmacother.pdf
Size:
552.44 KB
Format:
Adobe Portable Document Format